Literature DB >> 7979046

The molecular biology of fibroproliferative disorders of the skin: potential cytokine therapeutics.

E E Tredget1.   

Abstract

Mesh:

Substances:

Year:  1994        PMID: 7979046

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


× No keyword cloud information.
  6 in total

1.  Associations between keloid severity and single-nucleotide polymorphisms: importance of rs8032158 as a biomarker of keloid severity.

Authors:  Rei Ogawa; Atsushi Watanabe; Banyar Than Naing; Motoko Sasaki; Atsushi Fujita; Satoshi Akaishi; Hiko Hyakusoku; Takashi Shimada
Journal:  J Invest Dermatol       Date:  2014-02-04       Impact factor: 8.551

2.  Increased plasminogen activator inhibitor-1 in keloid fibroblasts may account for their elevated collagen accumulation in fibrin gel cultures.

Authors:  Tai-Lan Tuan; Huayang Wu; Eunice Y Huang; Sheree S N Chong; Walter Laug; Diana Messadi; Paul Kelly; Anh Le
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

3.  Role of Hyaluronic Acid Treatment in the Prevention of Keloid Scarring.

Authors:  Andrea Hoffmann; Jessica Lynn Hoing; Mackenzie Newman; Richard Simman
Journal:  J Am Coll Clin Wound Spec       Date:  2013-07-01

4.  Functional genomics unique to week 20 post wounding in the deep cone/fat dome of the Duroc/Yorkshire porcine model of fibroproliferative scarring.

Authors:  Loren H Engrav; Christopher K Tuggle; Kathleen F Kerr; Kathy Q Zhu; Surawej Numhom; Oliver P Couture; Richard P Beyer; Anne M Hocking; Gretchen J Carrougher; Maria Luiza C Ramos; Matthew B Klein; Nicole S Gibran
Journal:  PLoS One       Date:  2011-04-20       Impact factor: 3.240

5.  Regulation of Transforming Growth Factor β1, Platelet-Derived Growth Factor, and Basic Fibroblast Growth Factor by Silicone Gel Sheeting in Early-Stage Scarring.

Authors:  Jaehoon Choi; Eun Hee Lee; Sang Woo Park; Hak Chang
Journal:  Arch Plast Surg       Date:  2015-01-14

6.  The Immunosuppressant Fingolimod (FTY720) for the Treatment of Mechanical Force-Induced Abnormal Scars.

Authors:  Masayo Aoki; Akatsuki Kondo; Noriko Matsunaga; Azusa Honda; Yuri Okubo; Kazuaki Takabe; Rei Ogawa
Journal:  J Immunol Res       Date:  2020-01-07       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.